Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free FDBK Stock Alerts

Feedback (FDBK) Competitors

Feedback logo
GBX 6.70 -0.15 (-2.19%)
As of 09/11/2026 04:34 AM Eastern
Compare

FDBK vs. INHC, IQAI, DVRG, SENS, and TRLS

Should you buy Feedback stock or one of its competitors? Feedback's main competitors and comparable companies include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), and Trellus Health (TRLS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Feedback compare to Induction Healthcare Group?

Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
Induction Healthcare Group£12.57M0.72-£5.12M-£5.54N/A

Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -845.25%. Induction Healthcare Group's return on equity of -14.58% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Induction Healthcare Group -23.86%-14.58%-7.32%

Feedback has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the broader market.

24.8% of Feedback shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 8.0% of Feedback shares are held by insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Feedback's average media sentiment score of 0.75 beat Induction Healthcare Group's score of 0.00 indicating that Feedback is being referred to more favorably in the media.

Company Overall Sentiment
Feedback Positive
Induction Healthcare Group Neutral

Summary

Induction Healthcare Group beats Feedback on 8 of the 12 factors compared between the two stocks.

How does Feedback compare to IQ-AI?

IQ-AI (LON:IQAI) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

24.8% of Feedback shares are held by institutional investors. 66.0% of IQ-AI shares are held by company insiders. Comparatively, 8.0% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the broader market. Comparatively, Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market.

In the previous week, Feedback's average media sentiment score of 0.75 beat IQ-AI's score of 0.00 indicating that Feedback is being referred to more favorably in the news media.

Company Overall Sentiment
IQ-AI Neutral
Feedback Positive

IQ-AI has higher earnings, but lower revenue than Feedback.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Feedback£849.62K3.46-£10.84M-£15.74N/A

IQ-AI has a net margin of -77.52% compared to Feedback's net margin of -845.25%. Feedback's return on equity of -135.17% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Feedback -845.25%-135.17%-22.99%

Summary

Feedback beats IQ-AI on 6 of the 10 factors compared between the two stocks.

How does Feedback compare to DeepVerge?

DeepVerge (LON:DVRG) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

DeepVerge has a net margin of -19.81% compared to Feedback's net margin of -845.25%. DeepVerge's return on equity of -10.27% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
DeepVerge-19.81% -10.27% -5.56%
Feedback -845.25%-135.17%-22.99%

DeepVerge has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Feedback has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

4.2% of DeepVerge shares are held by institutional investors. Comparatively, 24.8% of Feedback shares are held by institutional investors. 9.5% of DeepVerge shares are held by company insiders. Comparatively, 8.0% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

DeepVerge has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DeepVerge£12.41M0.00-£2.46M-£0.01N/A
Feedback£849.62K3.46-£10.84M-£15.74N/A

In the previous week, Feedback's average media sentiment score of 0.75 beat DeepVerge's score of 0.00 indicating that Feedback is being referred to more favorably in the news media.

Company Overall Sentiment
DeepVerge Neutral
Feedback Positive

Summary

DeepVerge beats Feedback on 8 of the 11 factors compared between the two stocks.

How does Feedback compare to Sensyne Health?

Feedback (LON:FDBK) and Sensyne Health (LON:SENS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, Feedback's average media sentiment score of 0.75 beat Sensyne Health's score of 0.00 indicating that Feedback is being referred to more favorably in the media.

Company Overall Sentiment
Feedback Positive
Sensyne Health Neutral

Sensyne Health has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

24.8% of Feedback shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sensyne Health has a net margin of 0.00% compared to Feedback's net margin of -845.25%. Sensyne Health's return on equity of 0.00% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Sensyne Health N/A N/A N/A

Summary

Sensyne Health beats Feedback on 5 of the 9 factors compared between the two stocks.

How does Feedback compare to Trellus Health?

Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Feedback has a net margin of -845.25% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Trellus Health -6,826.32%-49.78%-22.76%

Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.46-£10.84M-£15.74N/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, indicating that its stock price is 151% more volatile than the broader market.

24.8% of Feedback shares are owned by institutional investors. Comparatively, 1.6% of Trellus Health shares are owned by institutional investors. 8.0% of Feedback shares are owned by company insiders. Comparatively, 9.6% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Feedback's average media sentiment score of 0.75 beat Trellus Health's score of 0.00 indicating that Feedback is being referred to more favorably in the media.

Company Overall Sentiment
Feedback Positive
Trellus Health Neutral

Summary

Trellus Health beats Feedback on 7 of the 12 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

Export
MetricFeedbackHealthcare Technology IndustryHealthcare SectorLON Exchange
Market Cap£2.94M£1.70B£7.16B£2.51B
Dividend Yield4.56%4.69%2.57%6.24%
P/E Ratio-0.4320.05274.94366.83
Price / Sales3.4688.35685.4389,753.13
Price / Cash1.1231.5776.6527.89
Price / Book0.125.9610.336.33
Net Income-£10.84M-£18.66M£3.50B£5.89B
7 Day Performance-4.29%-1.52%-3.32%-0.69%
1 Month Performance9.84%0.82%-0.53%0.00%
1 Year PerformanceN/A-14.70%23.51%19.96%

Feedback Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 6.70
-2.2%		N/A-49.6%£2.94M£849.62KN/A24
INHC
Induction Healthcare Group
N/AGBX 9.75
flat		N/A+0.0%£9.00M£12.57MN/A74
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:FDBK) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel